Stock Traders Purchase High Volume of VanEck Pharmaceutical ETF Put Options (NASDAQ:PPH)

VanEck Pharmaceutical ETF (NASDAQ:PPH) saw unusually large options trading activity on Tuesday. Traders acquired 21,566 put options on the stock. This is an increase of approximately 4,469% compared to the typical volume of 472 put options.

VanEck Pharmaceutical ETF Price Performance

Shares of PPH opened at $86.01 on Wednesday. The company has a market capitalization of $618.41 million, a P/E ratio of 24.60 and a beta of 0.72. VanEck Pharmaceutical ETF has a one year low of $77.67 and a one year high of $99.51. The business’s 50 day simple moving average is $88.42 and its 200-day simple moving average is $88.76.

VanEck Pharmaceutical ETF Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, April 4th. Shareholders of record on Tuesday, April 1st were paid a $0.5245 dividend. The ex-dividend date was Tuesday, April 1st. This represents a $2.10 dividend on an annualized basis and a yield of 2.44%. This is a positive change from VanEck Pharmaceutical ETF’s previous quarterly dividend of $0.31.

Institutional Trading of VanEck Pharmaceutical ETF

A number of hedge funds and other institutional investors have recently made changes to their positions in PPH. SBI Securities Co. Ltd. bought a new stake in VanEck Pharmaceutical ETF during the 4th quarter worth about $29,000. Activest Wealth Management bought a new stake in shares of VanEck Pharmaceutical ETF during the fourth quarter valued at approximately $32,000. Park Square Financial Group LLC bought a new stake in shares of VanEck Pharmaceutical ETF during the fourth quarter valued at approximately $43,000. Farther Finance Advisors LLC increased its holdings in shares of VanEck Pharmaceutical ETF by 391.0% in the first quarter. Farther Finance Advisors LLC now owns 545 shares of the company’s stock valued at $48,000 after purchasing an additional 434 shares in the last quarter. Finally, AE Wealth Management LLC lifted its holdings in VanEck Pharmaceutical ETF by 118.4% during the 1st quarter. AE Wealth Management LLC now owns 1,046 shares of the company’s stock worth $95,000 after buying an additional 567 shares in the last quarter.

VanEck Pharmaceutical ETF Company Profile

The VanEck Pharmaceutical ETF (PPH) is an exchange-traded fund that is based on the MVIS US Listed Pharmaceutical 25 index, a market-cap-weighted index of 25 of the largest global pharmaceutical firms. PPH was launched on Feb 1, 2000 and is managed by VanEck.